Vaccines to Stop Cancer Before It Starts | Durham News

Scientists are pioneering a revolutionary approach to cancer prevention by developing vaccines that train the immune system to destroy precancerous cells before they turn malignant—targeting those with Lynch syndrome, a genetic condition that dramatically increases cancer risk. With at least three vaccines in development and two already in early trials, researchers are seeing promising results, including reduced precancerous growths in participants. Personal stories like Dr. Stacy Norton’s—whose mother died of colon cancer and who carries the mutation herself—highlight the life-changing potential: sparing her children from lifelong screenings and anxiety. One vaccine uses mRNA tech similar to COVID-19 shots, while others target different markers. Though still early, this proactive strategy could redefine cancer care for millions genetically predisposed to the disease. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/07cc4c928fb32193